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Background
The incidence of inflammatory bowel diseases (IBD),
including Crohn’s disease (CD) and ulcerative colitis
(UC) is increasing worldwide [1]. These diseases result
in chronic, relapsing inflammation of the gastrointestinal
tract. The pathogenesis of IBD is currently thought to
involve an inappropriate and persistent inflammatory
response to commensal gut microbes in genetically sus-
ceptible individuals. Advances in DNA sequencing tech-
nology have led to the association of > 163 genetic
polymorphisms with risk for IBD. . However, in total,
these loci only account for about 13% of CD and 7% of
UC disease variance. Therefore, it appears that environ-
mental factors make the largest contributions to IBD
risk. Among the environmental factors associated with
IBD, diet and the intestinal microbiota are the most
likely to be modifiable making them targets for preven-
tion and treatment of IBD.
While nutritional therapy has been shown to be effica-
cious in the treatment of CD, the mechanism of action
has not been well characterized. Some hypotheses
involve reduction in luminal antigens and food exclu-
sion, a direct anti-inflammatory effect of the formula,
improved nutrition, and changes in the gut microbiota
[2-5]. The discovery that formula composition does not
impact outcome somewhat opposes the hypothesis that
enteral nutritional therapy is delivering a substance that
is beneficial to the gastrointestinal tract. A recent study
completed at our institution showed exclusive enteral
nutrition was similar to anti-TNF therapy for induction
of remission but partial enteral nutrition was inferior to
these therapies. Our data suggest that EEN is likely
effective based on exclusion of a “harmful” factor rather
than through more effective delivery of a specific
nutrient.
Modulation of the gut microbiota composition is a
proposed mechanism of action of enteral nutritional
therapy, although the current data are sparse [6]. The
available literature on this subject suggests that there is
a profound change in the fecal microbiota following
EEN therapy [3,6].
Conclusions
In summary, it is clear that enteral nutritional therapy is a
safe and effective approach to the treatment of Crohn’s
disease. Induction of remission and healing of the intest-
inal mucosa can be accomplished with enteral nutritional
therapy. Enteral nutritional therapy may also be effective
in maintaining remission and preventing post-operative
recurrence of disease following resection. An enhanced
understanding of the mechanism of action may allow for
the development of less restrictive protocols which achieve
the same effect. Additionally, mechanistic studies may help
to identify patient populations who may be more likely to
respond.
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